Journey Medical Corporation
DERM
$6.99
-$0.36-4.90%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -99.64% | -280.79% | -48.45% | 102.15% | 89.17% |
| Total Depreciation and Amortization | 4.61% | -9.11% | -23.52% | -27.01% | -20.49% |
| Total Amortization of Deferred Charges | -13.72% | -13.76% | -41.89% | -43.47% | 507.58% |
| Total Other Non-Cash Items | -20.66% | -15.77% | -37.23% | -50.45% | 31.53% |
| Change in Net Operating Assets | -45.25% | -127.55% | -201.58% | -196.28% | -143.91% |
| Cash from Operations | -689.63% | -274.18% | -255.50% | 1.69% | 107.66% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -200.00% | 100.00% | 100.00% | 100.00% |
| Cash from Investing | -- | -200.00% | 100.00% | 100.00% | 100.00% |
| Total Debt Issued | -33.33% | -76.74% | -39.55% | -47.37% | -60.53% |
| Total Debt Repaid | 92.19% | 97.59% | 98.88% | 76.09% | 27.27% |
| Issuance of Common Stock | 73.99% | 79.70% | 26,456.00% | 18,370.59% | 4,302.82% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 89.38% | 89.38% | -317.58% | -317.58% | -- |
| Cash from Financing | 688.79% | 453.73% | 210.92% | 284.93% | -162.60% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -46.28% | -56.31% | 77.44% | 132.76% | 86.59% |